![Fa Liu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Fa Liu
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Focus-X Therapeutics, Inc.
![]() Focus-X Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Full-Life Technologies Ltd., Focus-X Therapeutics, Inc. develops radio pharmaceuticals for cancer treatment. The company is based in Watchung, NJ. The company was founded in 2020 by Qi Hui, Fa Liu. Fa Liu has been the CEO since 2020. Focus-X Therapeutics was acquired by Full-Life Technologies Ltd. on March 31, 2023 for $245 million. | Directeur/Bestuurslid | 01-01-2020 | - |
Algemeen Directeur | 01-01-2020 | - | |
Oprichter | 01-01-2020 | - |
Loopbaan van Fa Liu
Statistieken
Internationaal
Verenigde Staten | 2 |
Operationeel
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Founder | 1 |
Sectoraal
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Focus-X Therapeutics, Inc.
![]() Focus-X Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Full-Life Technologies Ltd., Focus-X Therapeutics, Inc. develops radio pharmaceuticals for cancer treatment. The company is based in Watchung, NJ. The company was founded in 2020 by Qi Hui, Fa Liu. Fa Liu has been the CEO since 2020. Focus-X Therapeutics was acquired by Full-Life Technologies Ltd. on March 31, 2023 for $245 million. | Health Technology |